GSK Plc CEO Emma Walmsley doesn’t want the company’s employees spending any time thinking about the ongoing litigation over ...

GSK’s ViiV healthcare unit is countering rival HIV drugmaker Gilead’s recent global access moves with its own pledge to make at least 2 million doses of its long-acting pre-exposure prophylaxis (Pr | ...

DNA analysis company 23andme has been in trouble lately: data was breached in a 2023 hack, and this September the entire ...

Fortune noted that among the 55 women currently leading Fortune 500 companies, Barra is one of only nine who have been CEO ...

After several high-profile failures, including BMS’ $1.5B breakup with Agenus, anti-TIGIT therapies are generating cautious ...

If approved, the co-administration of Arexvy and Shingrix could provide a more convenient vaccination regimen for patients ...

DNA submitted by users to the genealogy company 23andMe will remain private for now, with CEO Anne Wojcicki saying she no ...

An activist invester has taken interest in pharma giant Pfizer, which despite becoming a household name during the pandemic ...

It also fit into GSK CEO Emma Walmsley’s strategy to focus on innovative medicines and vaccines and divest other assets. On Monday, GSK confirmed the planned closure of the Ulverston plant.

With a user base of more than 94 million—larger than the population of Germany—GCash is arguably the most popular Filipino ...